Jay M. Moyes, Director at PUMA BIOTECHNOLOGY, INC. (PBYI), sold 45,716 shares at $2.64 ($121K) on 2022-06-16, disclosed to the SEC on 2022-06-21.
Seasonal sale ($121k) by Director — this insider has traded PBYI in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.64 | 22,858 | $60K | 50.0% |
| 2 | $2.64 | 22,858 | $60K | 50.0% |
| Total | $2.64 avg | 45,716 | $121K | 100% |
| Filing → |
| SINT | BUY | 2025-08-27 | $11K | — | Filing → |
| PBYI | SELL | 2025-06-17 | $75K | — | Filing → |
| PBYI | SELL | 2024-06-17 | $73K | — | Filing → |